Mobile

A Phase IIa Randomized, Double-Blind, Parallel-Groups, Placebo-Controlled Clinical Trial to Study the Efficacy and Safety of MK-0724 Intravenous Infusion on the Amelioration of Neurological Damage and...

Mise à jour : Il y a 5 ans
Référence : EUCTR2008-002079-28

A Phase IIa Randomized, Double-Blind, Parallel-Groups, Placebo-Controlled Clinical Trial to Study the Efficacy and Safety of MK-0724 Intravenous Infusion on the Amelioration of Neurological Damage and Recovery from Middle Cerebral Artery Ischemic Stroke

Femme et Homme

  • | Pays :
    • -
  • | Organes :
    • -
  • | Spécialités :
    • -

Extrait

To compare the efficacy MK-0724 8 mg/kg/hr x 1 hr daily for 7 days to placebo in patients with middle cerebral artery ischemic stroke using the Day 90 Action Research Arm Test (ARAT) scores.

Critère d'inclusion

  • Middle cerebral artery ischemic stroke

Liens